The
transcription factor PU.1 is involved in regulation of macrophage differentiation and maturation. However, the role of PU.1 in alternatively activated macrophage (AAM) and asthmatic
inflammation has yet been investigated. Here we report that PU.1 serves as a critical regulator of AAM polarization and promotes the pathological progress of asthmatic airway
inflammation. In response to the challenge of DRA (dust mite, ragweed, and Aspergillus)
allergens, conditional PU.1-deficient (PU/ER(T)(+/-)) mice displayed attenuated allergic airway
inflammation, including decreased alveolar eosinophil infiltration and reduced production of
IgE, which were associated with decreased mucous glands and goblet cell
hyperplasia. The reduced asthmatic
inflammation in PU/ER(T)(+/-) mice was restored by adoptive transfer of IL-4-induced wild-type (WT) macrophages. Moreover, after treating PU/ER(T)(+/-) mice with
tamoxifen to rescue PU.1 function, the allergic asthmatic
inflammation was significantly restored. In vitro studies demonstrate that treatment of PU.1-deficient macrophages with
IL-4 attenuated the expression of
chitinase 3-like 3 (Ym-1) and
resistin-like molecule alpha 1 (Fizz-1), two specific markers of AAM polarization. In addition, PU.1 expression in macrophages was inducible in response to
IL-4 challenge, which was associated with phosphorylation of
signal transducer and activator of transcription 6 (STAT6). Furthermore, DRA challenge in sensitized mice almost abrogated gene expression of
Ym-1 and Fizz-1 in lung tissues of PU/ER(T)(+/-) mice compared with WT mice. These data, all together, indicate that PU.1 plays a critical role in AAM polarization and asthmatic
inflammation.